Posts

Big Tech and Big Pharma: How Medtech Can Bridge the Gap

As technologies evolve and  healthcare innovation  accelerates, the traditional boundaries separating medtech, big tech, and big pharma are increasingly blurry — but the cultural and strategic gaps between them remain. At LSI USA ’25, panelists Juan-Pablo Mas (Action Potential Venture Capital), Nishant Doctor (Surf Therapeutics), and Jordi Parramon (Nexus NeuroTech Ventures) joined moderator Katie Elias to examine how medtech can better align with  big tech and big pharma  to drive innovation forward. The conversation centered on key differences in development strategy, investor expectations, and business timelines — critical challenges that arise when building partnerships or raising capital across sectors. As medtech companies seek broader platforms and more ambitious outcomes, understanding and navigating these differences becomes essential for effective cross-sector collaboration and long-term success. Understanding the Evidence Gap A major area of divergence bet...
Post a Comment
Read more

The Next Frontier in Medical Robotics: Scaling Smarter

For years, medical robotics has been synonymous with high-cost, high-precision interventions — think large surgical robots in complex operating rooms. But a new generation of robotics companies is upending that paradigm by targeting more routine, high-volume procedures that strain provider bandwidth and expose systemic inefficiencies. At LSI USA ’25, a panel of operator-led companies took the stage to discuss how their technologies are addressing two of the biggest challenges in healthcare: provider scarcity and rising costs. While traditional robotics may have focused on elite surgical tasks, the next wave is all about scalable, task-specific solutions that work within real-world clinical and economic constraints. From Specialized to Scalable: Redefining the Role of Medical Robotics Rather than targeting a handful of high-reimbursement procedures, these companies are applying robotics to common clinical workflows —  vascular access , phlebotomy, biopsies — that collectively accoun...
Post a Comment
Read more

How to Build a Clear Path to Revenue that Attracts Investors and Acquirers

  This session broke down how to build a medtech business that actually makes money — and why that’s what investors and acquirers care about most. Featuring real-world strategies from AcuityMD, MY01, and Artelon, the panel focused on what it takes to turn clinical traction into commercial success. Watch this video for more information  https://www.youtube.com/watch?v=aYdGr8fTzv4&t=5s
Post a Comment
Read more

Signature Series: Unlocking the Potential of Device-Based Hypertension Therapies

Join moderator David Hochman (Orchestra BioMed, Inc.) and speaker Chris Eso (Medtronic) as they discuss groundbreaking innovations and strategic partnerships reshaping cardiac pacing, device-based hypertension therapies, and risk-reward sharing models in medtech. To get more information watch this video: https://www.youtube.com/watch?v=NNQD71Cv8Aw
Post a Comment
Read more

Why Invest in Medtech and Healthtech in Africa?

Africa’s healthcare market is poised for exponential growth. The population is expected to reach 2.5 billion by 2050, and urbanization is rising, with 50% of people already living in urban or peri-urban areas. These demographic shifts, combined with digital advancements, are creating new opportunities for medtech and healthtech in Africa. To read more about visit here:  https://www.slideshare.net/slideshow/why-invest-in-medtech-and-healthtech-in-africa/279622186  
Post a Comment
Read more

Why the Women’s Health Market Remains Underfunded

The women’s health market represents a massive and growing opportunity, yet it remains one of the most under-ventured sectors in healthcare. Despite women making up over half the population and accounting for the majority of healthcare spending decisions, investment in women’s health technologies and companies continues to lag. At LSI USA ’24,  a panel of industry leaders , including investors and innovators, gathered to dissect why this gap persists and, more importantly, how to close it. Defining the Women’s Health Market Before addressing the investment challenges, the panelists established a broad and inclusive definition of women’s health. “Women’s health is anything that impacts a woman’s well-being and ability to thrive — physically, mentally, and emotionally,”  said Tara Ghazi, Co-Founder and Chief Business Officer of  MALCOVA . To read more about visit   https://www.slideshare.net/slideshow/why-the-women-s-health-market-remains-underfunded/276723360  
Post a Comment
Read more

Medtech and Healthtech in Africa: Opportunities and Investment

Africa’s healthcare landscape is undergoing a transformation driven by digital health, medtech, and biotech innovations. With a rapidly growing population, increasing urbanization, and rising demand for better healthcare solutions, medtech and healthtech in Africa present a significant investment opportunity. However, challenges such as infrastructure gaps, regulatory complexity, and access to funding remain. During  a panel at LSI USA  ’24, Kwame Ulmer, Managing Partner at MedTech Impact Partners, sat down with Sewu-Steve Tawia, Co-Founder & Managing Partner of Jaza Rift Ventures, to explore the realities of investing in Africa’s healthcare ecosystem. Their conversation shed light on the continent’s vast potential, the hurdles to overcome, and the strategies that can drive innovation and investment success. Why Invest in Medtech and Healthtech in Africa? Africa’s healthcare market is poised for exponential growth. The population is expected to reach 2.5 billion by 2050, a...
Post a Comment
Read more